Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Cannabis Use on Sedation Requirements for Oral Surgery Procedures
NCT05873465Phase 4Withdrawn
- Sponsor
- University of Oklahoma
- Start
- Mar 2023
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of propofol, midazolam, fentanyl, sponsored by University of Oklahoma. Planned start Mar 2023; status: withdrawn.
02
Drugs
propofolmidazolamfentanyl
Beyond the preview
Go deeper on NCT05873465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05873465.